Amgen’s Targeted Cancer Drug Shows Early Promise in New Areas

(Bloomberg) -- Amgen Inc.’s buzzed-about cancer treatment showed some promising signs that the experimental medicine might work in different tumor types.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.